NO141262C - Analogifremgangsmaate til fremstilling av terapeutisk virksomme tripeptider - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk virksomme tripeptider

Info

Publication number
NO141262C
NO141262C NO740546A NO740546A NO141262C NO 141262 C NO141262 C NO 141262C NO 740546 A NO740546 A NO 740546A NO 740546 A NO740546 A NO 740546A NO 141262 C NO141262 C NO 141262C
Authority
NO
Norway
Prior art keywords
tripeptides
preparation
therapeutically effective
analogy procedure
analogy
Prior art date
Application number
NO740546A
Other languages
English (en)
Other versions
NO740546L (no
NO141262B (no
Inventor
Masahiko Fujino
Tsunehiko Fukuda
Chitoshi Hatanaka
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO740546L publication Critical patent/NO740546L/no
Publication of NO141262B publication Critical patent/NO141262B/no
Publication of NO141262C publication Critical patent/NO141262C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO740546A 1973-02-23 1974-02-19 Analogifremgangsmaate til fremstilling av terapeutisk virksomme tripeptider NO141262C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2254473A JPS5714337B2 (no) 1973-02-23 1973-02-23

Publications (3)

Publication Number Publication Date
NO740546L NO740546L (no) 1974-08-26
NO141262B NO141262B (no) 1979-10-29
NO141262C true NO141262C (no) 1980-02-06

Family

ID=12085750

Family Applications (1)

Application Number Title Priority Date Filing Date
NO740546A NO141262C (no) 1973-02-23 1974-02-19 Analogifremgangsmaate til fremstilling av terapeutisk virksomme tripeptider

Country Status (15)

Country Link
US (1) US3912705A (no)
JP (1) JPS5714337B2 (no)
AT (1) AT335085B (no)
AU (1) AU475886B2 (no)
BE (1) BE811467A (no)
CA (1) CA1032934A (no)
CH (1) CH594609A5 (no)
DE (1) DE2408324A1 (no)
FR (1) FR2219154B1 (no)
GB (1) GB1434147A (no)
HK (1) HK15479A (no)
HU (1) HU170645B (no)
NL (1) NL7402487A (no)
NO (1) NO141262C (no)
SE (1) SE400074B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959248A (en) * 1974-04-03 1976-05-25 Merck & Co., Inc. Analogs of thyrotropin-releasing hormone
NL183764C (nl) * 1974-10-16 1989-01-16 Gruenenthal Gmbh Werkwijze voor de bereiding van een geneesmiddel met psychotrope of neurotrope werking en werkwijze voor de bereiding van een histidylprolineamide-derivaat.
AU504840B2 (en) 1975-09-09 1979-11-01 Takeda Chemical Industries Ltd Medicinal compositions
AU4125578A (en) * 1977-11-09 1979-05-17 Merck & Co Inc Tripeptides
US4328134A (en) * 1980-05-06 1982-05-04 Schally Andrew Victor Anorexigenic peptides
US4426378A (en) 1981-04-09 1984-01-17 The United States Of America As Represented By The Secretary Of The Army Thyrotropin releasing hormone in therapy of shock and as a central nervous system stimulant
JPS59155346A (ja) * 1983-02-24 1984-09-04 Itsuro Sofue ペプタイド
JPS60190795A (ja) * 1984-03-09 1985-09-28 Takeda Chem Ind Ltd ペプタイド
US4608365A (en) * 1984-03-30 1986-08-26 University Of Southern California Treatment of neurologic functions
BR112016025076B1 (pt) * 2014-04-30 2022-03-03 Syngenta Participations Ag Processo para a preparação de ciclosserinas substituídas e seus compostos
AR129405A1 (es) * 2022-05-30 2024-08-21 Syngenta Crop Protection Ag Procedimiento para la preparación de 2-oxazolidinonas 4-sustituidas

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821188A (en) * 1972-06-14 1974-06-28 American Home Prod Proline and pyroglutamic acid containing tripeptides

Also Published As

Publication number Publication date
GB1434147A (en) 1976-05-05
DE2408324A1 (de) 1974-08-29
FR2219154B1 (no) 1978-01-06
FR2219154A1 (no) 1974-09-20
NL7402487A (no) 1974-08-27
US3912705A (en) 1975-10-14
AU475886B2 (en) 1976-09-09
HU170645B (no) 1977-07-28
JPS49108075A (no) 1974-10-14
NO740546L (no) 1974-08-26
AT335085B (de) 1977-02-25
CH594609A5 (no) 1978-01-13
JPS5714337B2 (no) 1982-03-24
SE400074B (sv) 1978-03-13
BE811467A (fr) 1974-08-22
AU6584474A (en) 1975-08-21
ATA138074A (de) 1976-06-15
HK15479A (en) 1979-03-30
NO141262B (no) 1979-10-29
CA1032934A (en) 1978-06-13

Similar Documents

Publication Publication Date Title
NO145691C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme decapeptidamider
NO146200C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 16-oksygenerte prostansyrederivater
NO145273C (no) N-formyl-alfa-l-aspartyl-l-fenylalanin for anvendelse til fremstilling av alfa-l-aspartyl-l-fenylalaninalkylestere
NO139560C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
SE423631B (sv) Forfarande for framstellning av oxaalhyl-dialkylxantiner
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
SE7710599L (sv) Forfarande for framstellning av bensisoxazoler
NO143796C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme piperazinyliminorifamyciner
NO142303C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater
SE411212B (sv) Forfarande for framstellning av 3-halogen-cefalosporiner
NO141755C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme dotriacontapeptidamider
NO141262C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme tripeptider
NO146022C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme benzofenonderivater
NO146596C (no) Fremgangsmaate for fremstilling av 6-deoksytetracykliner
NO139861C (no) Fremgangsmaate til fremstilling av 1-hydroksy-2-pyridoner
SE417601B (sv) Forfarande for framstellning av amidinokarbamider
NO790627L (no) Fremgangsmaate for fremstilling av hydroksyalkylxantiner
NO142260C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater
NO843825L (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin
SE417319B (sv) Analogiforfarande for framstellning av ergopeptiner
NO147754C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme cefemderivater.
SE411211B (sv) Forfarande for framstellning av 3-halogencefalosporiner
SE409994B (sv) Forfarande for framstellning av amidinokarbamider
NO146141C (no) Fremgangsmaate til fremstilling av aminocyklitolantibiotika
NO142035C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme substituerte triazoler